Prof Katie Atkins

Prof of Infectious Disease Epidemiology

United Kingdom

Email
Katie

I am an infectious disease modeller with a particular interest in evolutionary epidemiology. I hold a joint position between LSHTM and the University of Edinburgh Medical School. Group members are listed on my website katiito.com.

Affiliations

Department of Infectious Disease Epidemiology and Dynamics

Faculty of Epidemiology and Population Health

Centres

Centre for Mathematical Modelling of Infectious Diseases

Antimicrobial Resistance Centre

Global Health Economics Centre

Teaching

I am co-organiser of the hybrid Modern Techniques in Modelling at LSHTM.

Research

I work across epidemiology, phylogenetics and mathematical modelling. The areas where I am currently active include HIV transmission, antimicrobial resistance and vaccines (particularly PCV and those against RSV).

Selected Publications

Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline.

Baxter, J; Villabona-Arenas, CJ; Thompson, RN; Hué, S; Regoes, RR; Kouyos, RD; Günthard, HF; Albert, J; Leigh Brown, A; ATKINS, KE;

2024

Journal of the Royal Society, Interface / the Royal Society

Estimating the risk and spatial spread of measles in populations with high MMR uptake: Using school-household networks to understand the 2013 to 2014 outbreak in the Netherlands.

Munday, JD; ATKINS, KE; Klinkenberg, D; Meurs, M; Fleur, E; Hahné, SJ; Wallinga, J; Jan van Hoek, A;

2024

PLoS medicine

Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829].

HODGSON, D; Wilkins, N; VAN LEEUWEN, E; Watson, CH; Crofts, J; FLASCHE, S; Jit, M; ATKINS, KE;

2024

The Lancet regional health. Europe

Anticipating the risk and spatial spread of measles in populations with high MMR uptake: using school-household networks to understand the 2013 - 2014 outbreak in the Netherlands

Munday, JD; ATKINS, KE; Klinkenberg, D; Meurs, M; Fleur, E; Hahne, S; Wallinga, J; Van Hoek, AJ;

2024

Cold Spring Harbor Laboratory

Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination.

HODGSON, D; Wilkins, N; VAN LEEUWEN, E; Watson, CH; Crofts, J; FLASCHE, S; JIT, M; ATKINS, KE;

2024

The Lancet Regional Health Europe

Genomic epidemiology of SARS-CoV-2 variants during the first two years of the pandemic in Colombia.

Jimenez-Silva, C; Rivero, R; Douglas, J; Bouckaert, R; Villabona-Arenas, CJ; ATKINS, KE; Gastelbondo, B; Calderon, A; Guzman, C; Echeverri-De la Hoz, D; Muñoz, M; Ballesteros, N; Castañeda, S; Patiño, LH; Ramirez, A; Luna, N; Paniz-Mondolfi, A; Serrano-Coll, H; Ramirez, JD; Mattar, S; Drummond, AJ;

2023

Communications medicine

Vaccination of Older Adults Against Respiratory Syncytial Virus: The Final Pieces of the Puzzle.

ATKINS, KE; HODGSON, D;

2023

Clinical infectious diseases

Inferring the multiplicity of founder variants initiating HIV-1 infection: a systematic review and individual patient data meta-analysis.

Baxter, J; Langhorne, S; Shi, T; TULLY, DC; Villabona-Arenas, CJ; Hué, S; Albert, J; Leigh Brown, A; ATKINS, KE;

2023

Lancet Microbe

Evaluating the impact of Respiratory Syncytial Virus immunisation strategies on antibiotic use and drug resistant bacterial infections in England

ATKINS, KE; Hodgson, D; Jit, M; DAVIES, NG;